Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Freud's adolescence and the prolegomena to psychoanalysis.
Hypoxia-induced changes in pulmonary and systemic vascular resistance: where is the O2 sensor?
Macroscopic properties of spontaneous mutations in slow-channel syndrome: correlation by domain and disease severity.
Trial Readiness in Cavernous Angiomas with Symptomatic Hemorrhage
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. J Pathol. 2004 Mar; 202(3):336-40.
View in:
PubMed
subject areas
Cystadenoma, Mucinous
Cystadenoma, Papillary
Cystadenoma, Serous
Female
Humans
Mutation
Ovarian Neoplasms
Proto-Oncogene Proteins
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins c-raf
Proto-Oncogene Proteins p21(ras)
ras Proteins
authors with profiles
Thomas Krausz